Optimal scoring of serial change on chest radiography in sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 28, Issue 2, 2011, Pages 130-138

  Zappala, C J ^a,d   Desai, S R ^b   Copley, S J ^c   Spagnolo, P ^a   Cramer, D ^a   Sen, D ^a   Alam, S M ^a   Du Bois, R M ^a   Hansell, D M ^a   Wells, Athol U ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chest radiograph; Pulmonary function tests; Sarcoidosis; Scadding stage

Indexed keywords

CARBON MONOXIDE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; FEMALE; GAS DIFFUSION; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONDON; LUNG; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DIFFUSING CAPACITY; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VITAL CAPACITY; YOUNG ADULT;

EID: 81455155084     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. ATS/ERS/WASOG. Statement on Sarcoidosis. American Journal of Respiratory and Critical Care Medicine 1999; 160: 736-55.
2. Judson MA, Baughman RP, Thompson BW, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasculitis Diffuse Lung Disease 2003; 20: 201-11.
3. Winterbauer RH, Hutchinson JF. Clinical significance of pulmonary function tests. Chest 1980; 78 (4): 640-7. (Pubitemid 10005888)
4. Sones M, Israel HL. Course and prognosis of sarcoidosis. American Journal of Medicine July 1960: 84-93.
5. Scadding JG. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. British Medical Journal 1961; 2: 1267-78.
6. Lieberman J, Schleissner LA, Nosal, Sastre A, Mishkin FS. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. Chest 1983; 84 (5): 522-8.
7. Baumann MH, Strange C, Sahn SA. Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal? American Journal of Radiology 1990; 154: 481-5. (Pubitemid 20071593)
8. Muers MF, Middleton WG, Gibson GJ, et al. A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society study of long-term corticosteroid treatment. Sarcoidosis Vasculitis Diffuse Lung Disease 1997; 14: 46-56. (Pubitemid 27170555)
9. Judson MA, Gilbert GE, Rodgers JK, et al. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology 2008; 13: 97-102.
10. Emirgil C, Sobol BJ, Williams MH. Long-term study of pulmonary sarcoidosis. Journal of Chronic Disease 1969; 22: 69-86.
11. Baughman RP, Desai S, Drent M, et al. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparion of different methods of evaluation. Chest 2009; 136: 526-35.
12. Mihailovic-Vucinic V, Zugic V, Videnovic-Ivanov J. Hew observations on pulmonary function changes in sarcoidosis. Current opinion in pulmonary medicine 2003; 9: 436-41. (Pubitemid 36994075)
13. Sharma OP, Colp C, Williams MH. Pulmonary function studies in patients with bilateral sarcoidosis of hilar lymph nodes. Archives of Internal Medicine 1966; 117: 436-40.
14. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. American Journal of Respiratory and Critical Care Medicine 2003; 168 (10): 1162-6. (Pubitemid 37424039)
15. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. American Journal of Respiratory and Critical Care Medicine Sep 2005; 172 (6): 721-8. (Pubitemid 41324227)
16. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Report of working party. Standardized lung function testing. Official statement of the European Respiratory Society. European community of steel & coal. European Respiratory Journal 1993; 16: 1-100.
17. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996; 51: 238-47.
18. Baughman RP, Winget DB, Bowen EH, Lower EE. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasculitis Diffuse Lung Disease 1997; 14 (2): 154-8. (Pubitemid 27427348)
19. Huang CT, Heurich AE, Rosen Y, Moon S, Lyons HA. Pulmonary sarcoidosis. Roentgenographic, functional and pathologic correlations. Respiration 1979; 37: 337-45. (Pubitemid 9171187)
20. Colp C. Sarcoidosis. Course and treatment. Medical Clinics of North America 1977; 61 (6): 1267-78. (Pubitemid 8253981)
21. Baughman RP, Engel PJ, Meyer CA, Barrett AB, Lower EE. Pulmonary hypertension in sarcoidosis. Sarcoidosis, Vasculitis, Diffuse Lung Disease 2006; 23 (2): 108-16. (Pubitemid 47471829)
22. Bourbonnais JM, Samavati L. Clinical predictors of pulmonary hypertension in sarcoidosis. European Respiratory Journal Aug 2008; 32 (2): 296-302.